The Scotts Miracle-Gro Company Stock Price and Value Analysis

The Scotts Miracle-Gro Company (NYSE:SMG) in our automated value investing analysis, with the cash flow history and price comparison below.

Key Facts

Advertisement helps keep Trendshare free for most readers.

Hold-time calculator

Estimate how long you need to hold The Scotts Miracle-Gro Company to reach your target.

Target type

SMG Free Cash Flow Trend

Free Cash Flow trendline for SMG
Free Cash Flow trendline for The Scotts Miracle-Gro Company
CSV

Based on historical returns, we believe that The Scotts Miracle-Gro Company can grow its free cash at a rate of about 8%. That's positive!

AdvantagesDisadvantagesNeutral
  • This company is making money at a decent rate.
  • This company is less known than others.
  • This stock looks overpriced.
  • This company has wild ups and downs.
  • This company pays no dividend.

Inside the SMG Numbers

SMG Price
(The Scotts Miracle-Gro Company stock price per share)
$58.60
[?] SMG Fair Price
(based on intrinsic value)
$1.90
[?] SMG Safety Price (based on a variable margin of safety) $1.14
Try your own return

The fair price above uses a 10.1% discount rate, the long-run US stock return (10.1% geometric, 1926 to 2025, from Bessembinder's working paper, updated 2026-11-09), and 2.5% terminal growth. A higher rate suits a higher return target and gives a lower value.

Value per share:

[?] PE Ratio versus Sector 33% higher than other Basic Materials stocks
[?] PE Ratio versus Industry 7% lower than other Agricultural Chemicals stocks
[?] Cash Yield -1.35%
[?] Free Cash Flow Jitter 71%

Insider Activity Summary

No open-market insider buys or sells are recorded for the last 12 months.

This stock has short interest! This means that people have shorted it.

Why does that matter? They've made a bet that price will decrease from where they bought it. Maybe there are financial problems, or maybe there's a value play.

As of the latest analysis, there are 5,155,069 shares shorted. With 44,361,880 shares available for purchase and an average trading volume over the past 10 trading days of 901,200, it would take at least 5.7 days for all of the short holders to cover their shorts.

Related guides: good annual rate of return · high-yield stocks · forecasting earnings growth

Free Cash Flow by Fiscal Year

How to read this: free cash flow in plain terms, free cash flow jitter.

Each year names the SEC filer that reported it, so a change of filer shows up here.

Fiscal yearSEC filer (CIK)Free cash flow (USD millions)
2008 825542 145
2009 825542 201
2010 825542 225
2011 825542 51
2012 825542 82.7
2013 825542 270
2014 825542 166
2015 825542 177
2016 825542 177
2017 825542 296
2018 825542 273
2019 825542 167
2020 825542 498
2021 825542 202
2022 825542 -208
2023 825542 447
2024 825542 576
2025 825542 272

Download the yearly data as CSV.

Cash Conversion

How to read this: what free cash flow is, why earnings matter.

Over the 14 fiscal years from 2008 to 2025 with positive net income, operating cash flow totaled $4,043 million against net income of $3,222 million, or 1.25 times. Net income was negative in 4 of the 18 years, and those years are left out of the ratio.

In 2025, operating cash flow was 2.56 times net income, compared with 1.57 times for the earliest three years (2008 to 2010).

In 2025, capital expenditures were $97.4 million, 26.2% of operating cash flow of $371 million, which leaves an estimated $274 million after capex. Across the 17 years with reported capex, it averaged 22.9% of operating cash flow. This uses that year's own capital expenditures, not the five-year average behind the free cash flow table, so the two can differ.

Fiscal yearNet income (USD millions)Operating cash flow (USD millions)Capital expenditures (USD millions)Operating cash flow / net income
2008 -10.9 201 56.1 n/a
2009 153 265 72 1.73
2010 204 296 83.4 1.45
2011 168 122 72.7 0.73
2012 107 153 69.4 1.44
2013 161 342 60.1 2.12
2014 167 241 87.6 1.45
2015 160 247 61.7 1.55
2016 315 244 58.3 0.77
2017 218 363 69.6 1.66
2018 63.7 343 68.2 5.38
2019 461 227 42.4 0.49
2020 387 558 62.7 1.44
2021 513 272 107 0.53
2022 -438 -129 114 n/a
2023 -380 531 92.8 n/a
2024 -34.9 668 84 n/a
2025 145 371 97.4 2.56

Where the Cash Went

How to read this: why companies buy back shares, dividend yield explained.

Over the 10 fiscal years from 2016 to 2025 with dividend or share repurchase facts, estimated free cash flow totaled $2,699 million. That estimate uses the average of up to five years of capital expenditures, not each year's own, so it is not a reported figure.

In the 10 of those years with dividend payment facts, dividends paid totaled $1,657 million, 61.4% of the estimated free cash flow of those years. Estimated free cash flow was at least the dividends paid in 9 of those 10 years.

In 6 of the 10 years, cash spent repurchasing shares was at least 5% of that year's estimated free cash flow, and in those years it totaled $921 million. Smaller amounts are left out of this sentence because they can be shares withheld to pay employees' taxes on stock awards.

In 2025, dividends and cash spent repurchasing shares together were $173 million, 63.4% of estimated free cash flow of $272 million.

Fiscal yearEstimated free cash flow (USD millions)Dividends paid (USD millions)Cash spent repurchasing shares (USD millions)Total returned (USD millions)Total as a percent of estimated free cash flow
2016 177 117 137 254 143.8%
2017 296 120 255 376 127.0%
2018 273 120 328 448 163.7%
2019 167 125 3.1 128 76.5%
2020 498 411 53.2 464 93.3%
2021 202 143 129 272 135.1%
2022 -208 166 258 424 n/a
2023 447 149 9.3 158 35.4%
2024 576 151 5.1 156 27.2%
2025 272 154 18.4 173 63.4%

Free cash flow here is an estimate: operating cash flow less the average of up to five years of capital expenditures. Cash spent repurchasing shares can include shares withheld to pay employees' taxes on stock awards. The entry n/a means the filings gave no usable figure, not that the amount was zero. Source: the company's annual reports to the SEC.

Revenue and Cash Margin

How to read this: earnings and margins.

Revenue was $2,823 million in 2008 and $3,413 million in 2025, a compound annual growth rate of 1.1% over 17 years.

Revenue fell 3.9% from 2024 to 2025.

Our estimated free cash flow was $272 million in 2025, 8.0% of revenue. In 2008 the estimated margin was 5.1%. This estimate charges each year with the average of up to five years of capital expenditures, so it is not the free cash flow the company reported.

Fiscal yearRevenue (USD millions)Estimated free cash flow (USD millions)Estimated free cash flow / revenue
2008 2,823 145 5.1%
2009 2,746 201 7.3%
2010 2,873 225 7.8%
2011 2,800 51 1.8%
2012 2,771 82.7 3.0%
2013 2,774 270 9.8%
2014 2,841 166 5.9%
2015 3,017 177 5.9%
2016 2,506 177 7.0%
2017 2,642 296 11.2%
2018 2,663 273 10.3%
2019 3,156 167 5.3%
2020 4,132 498 12.0%
2021 4,925 202 4.1%
2022 3,924 -208 -5.3%
2023 3,551 447 12.6%
2024 3,553 576 16.2%
2025 3,413 272 8.0%

Balance Sheet

How to read this: how debt and assets are compared, the current ratio.

In 2025, cash and equivalents were $36.6 million against total liabilities of $3,100 million, or 1.2% of total liabilities. Total liabilities include everything the company owes, not only borrowed money.

Total liabilities were 113.0% of total assets in 2025, compared with 73.7% in 2009, an increase of 39.4 percentage points.

Stockholders equity was negative in 2025, at -$358 million, which means the company's liabilities and other claims on its assets exceeded the assets themselves. Companies that return cash through large buybacks can show negative equity for that reason alone, but it also leaves no book value cushion for shareholders.

Based on our estimated free cash flow, cash flow return on invested capital (CROIC) was 13.9% in 2025. Invested capital here is total assets less cash and current liabilities.

Fiscal yearTotal assets (USD millions)Cash and equivalents (USD millions)Total liabilities (USD millions)Stockholders equity (USD millions)
2009 2,220 70.6 1,636 585
2010 2,164 88.1 1,400 765
2011 2,052 131 1,492 560
2012 2,074 132 1,473 602
2013 1,937 130 1,227 711
2014 2,058 64.9 1,491 567
2015 2,527 50.8 1,894 633
2016 2,756 28.6 2,022 734
2017 2,747 121 2,085 662
2018 3,055 33.9 2,695 360
2019 3,029 18.8 2,306 723
2020 3,381 16.6 2,678 703
2021 4,800 244 3,787 1,013
2022 4,297 86.8 4,149 148
2023 3,414 31.9 3,681 -267
2024 2,872 71.6 3,263 -391
2025 2,742 36.6 3,100 -358

Price Versus Our Estimated Value

Positive free cash flow appears in 17 of the 18 fiscal years we hold for The Scotts Miracle-Gro Company from its current SEC filer.

The Scotts Miracle-Gro Company is priced at $58.60, above our fair value estimate of $1.90 and its safe value of $1.14.

Free cash flow from the first three years of data averaged $190 million, and from the last three $432 million: a sharp rise.

Free cash flow is volatile from year to year, with a variability measure of 71%.

Dividends are not in our data for The Scotts Miracle-Gro Company.

These figures are automated calculations from SEC filings and the recent price. They are not a recommendation to buy or sell. See how we estimate value.

Compared With Its Sector and Industry

How to read this: the price to earnings ratio.

Its trailing P/E ratio is 33% above the average for stocks in the Basic Materials sector.

Its trailing P/E ratio is 7% below the average for stocks in the Agricultural Chemicals industry.

A P/E ratio depends on trailing earnings, which one-time items can distort, so a lower P/E is not by itself evidence of value.

SEC Filer History

Every fiscal year on this page is reported by one SEC filer, CIK 825542.

Each figure on this page comes from that filer.

Risks to This Analysis

How to read this: understanding investment risk.

  • Free cash flow was negative in 1 of the 18 years we have.
  • Free cash flow is volatile from year to year, so the estimates depend heavily on which years are included.
  • These figures are automated calculations from SEC filings and the recent price. They may contain errors, and they do not reflect lawsuits, management changes, or other events the filings do not show.

How This Page Is Made

Latest annual report used
Fiscal year 2025
Price and market data last refreshed
2026-11-20
Model assumptions last reviewed
2026-11-09

Company figures come from the annual reports (Form 10-K) that each company files with the SEC, read from the SEC EDGAR company facts data. The share price and other market data come from a market data provider.

Free cash flow here is operating cash flow minus capital spending. To keep one unusual year from swinging the result, each year is charged with the average of up to five years of capital spending, so the figure is an estimate and not the free cash flow a company reports.

The fair price is the present value of ten years of projected free cash flow plus a terminal value, discounted at 10.1 percent a year, the long-run return of US stocks, with 2.5 percent growth after year ten. The figures on this page are estimates, not advice.

This analysis covers US companies that file 10-K annual reports. Free cash flow describes banks, real estate investment trusts and funds poorly, so treat their figures with extra caution. In the cash returned and balance sheet tables, a value of zero is treated as a gap in the data, not as a real zero.

Read the filings yourself: SMG annual reports (10-K) on SEC EDGAR. To try your own growth rate, use the intrinsic value calculator on this page. Our editorial standards explain how Trendshare handles its sources and corrections.

Advertisement supports free stock analysis content.

Questions to Answer Before You Invest in SMG

Does The Scotts Miracle-Gro Company have a coherent story? Does it have a plan to continue to make money? Is it worth your time? Only you can decide where to go from here. Our investment guide helps you ask the right questions, including how to buy stocks. Use these research links for more information.

Worked example: SMG

This example shows how we apply the Trendshare checklist to SMG: earnings power, cash generation, valuation, and margin of safety.

We check: business quality, free cash flow, P/E, and margin of safety.

  1. Step 1 — Snapshot

    • Price: 58.60
    • Market cap: $3.4B
    • EPS: 3.3
  2. Step 2 — Valuation checks

    • P/E: 17.758
    • FCF yield: -1.3%
    • Date checked: Nov 20, 2026
  3. Step 3 — Margin of safety

    • Compare price to fair value and safety price.
    • Look for durable cash generation and reasonable leverage.
    • Decide if it passes your personal checklist.